Nirmatrelvir-ritonavir for nonhospitalized patients with COVID-19: Case-based approach to assessment and treatment

Can Fam Physician. 2023 Aug;69(8):546-549. doi: 10.46747/cfp.6908546.
No abstract available

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19 Drug Treatment
  • COVID-19*
  • Humans
  • Ritonavir* / therapeutic use

Substances

  • nirmatrelvir
  • Ritonavir
  • Antiviral Agents